The growing use of a popular drug in the long-term treatment of bipolar disorder is based largely on a single, flawed clinical trial that may be steering doctors and patients away from drugs with a more established track record, a new review published this week in the journal "PLoS Medicine" suggests.

Source: http://rss.cnn.com/~r/rss/cnn_health/~3/Yp1ndNF5cmM/index.html
padres milwaukee brewers yankees san diego padres
No comments:
Post a Comment